
    
      The purpose and objective is to assess the safety and efficacy of the Resolute Integrity
      Stent for the treatment of de novo lesions in native coronary arteries with a reference
      vessel diameter(RD) of 2.25mm to 4.2mm in two groups of patients, specifically those patients
      receiving stents less than or equal to 30mm in length.
    
  